Yasutoshi Shiratori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasutoshi Shiratori has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
Katsuyuki Fukuda
Department of Gastroenterology, St. Luke’s International University, Tokyo, Japan
22 shared publicationsTakashi Ikeya
Department of Gastroenterology, St. Luke's International Hospital
19 shared publicationsAnthony Kalloo
Johns Hopkins University School of Medicine, Maryland, USA
12 shared publicationsNaoki Ishii
Division of Gastroenterology, Kuki General Hospital, Tokyo, Japan
12 shared publicationsKenji Nakamura
Division of Gastroenterology, Tokyo Dental College Ichikawa General Hospital, Tokyo, Japan
8 shared publications- Naoki Ishii
Division of Gastroenterology Shin‐Kuki General Hospital Saitama Japan
7 shared publications
Latest Publications
- 4 November 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (11)
Strengthening Data Validation in the Japan Endoscopy Database
- 4 November 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (11)
Strengthening Data Validation in the Japan Endoscopy Database
- 16 July 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (2) , 203-204
Routine terminal ileal intubation: reconsidering its role in screening colonoscopy
- 16 July 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 104 (2) , 203-204
Routine terminal ileal intubation: reconsidering its role in screening colonoscopy
- 29 May 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (5) , 940-948
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities
Racial disparities in gastric cancer (GC) outcomes have gained increasing attention in the United States, particularly given the large immigrant population from high-incidence regions. We analyzed a nationally representative hospital database (2003-2022) to identify patients with a primary diagnosis of gastric cancer. Outcomes included in-hospital mortality, surgical receipt, perioperative complications, length of stay, and home discharge. Multivariate logistic regression adjusting for sociodemographic and hospital factors estimated odds ratios (ORs) with 95% confidence intervals. Temporal trends and race-period interactions were analyzed to assess in-hospital mortality changes, with regional subgroup analyses evaluating geographic variation. A total of 137,951 patients were included. GC admissions and in-hospital mortality declined by 82% and 60% over two decades; however, racial disparities persisted. Compared with White patients, Black (OR 1.17, 95% CI 1.11-1.25) and Native American patients (OR 1.14, 95% CI 1.04-1.26) had higher odds of in-hospital mortality. The Black-White mortality gap narrowed during 2013-2018 but widened after 2019, indicating temporal heterogeneity (P for interaction = 0.026). Black patients underwent surgery less frequently (OR 0.85), experienced more perioperative complications (OR 1.11), and were less often discharged home (OR 0.86). Regionally, mortality was higher among Black patients in the Northeast (OR 1.36) and South (OR 1.14), and among Asian (OR 1.35) and Native American patients (OR 1.47) in the West. Despite improvements in GC admissions and in-hospital mortality, clinically relevant racial and regional disparities in hospital-based outcomes persist, highlighting the need for targeted public health and health system strategies to achieve equitable care.
- 29 May 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (5) , 940-948
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities
Racial disparities in gastric cancer (GC) outcomes have gained increasing attention in the United States, particularly given the large immigrant population from high-incidence regions. We analyzed a nationally representative hospital database (2003-2022) to identify patients with a primary diagnosis of gastric cancer. Outcomes included in-hospital mortality, surgical receipt, perioperative complications, length of stay, and home discharge. Multivariate logistic regression adjusting for sociodemographic and hospital factors estimated odds ratios (ORs) with 95% confidence intervals. Temporal trends and race-period interactions were analyzed to assess in-hospital mortality changes, with regional subgroup analyses evaluating geographic variation. A total of 137,951 patients were included. GC admissions and in-hospital mortality declined by 82% and 60% over two decades; however, racial disparities persisted. Compared with White patients, Black (OR 1.17, 95% CI 1.11-1.25) and Native American patients (OR 1.14, 95% CI 1.04-1.26) had higher odds of in-hospital mortality. The Black-White mortality gap narrowed during 2013-2018 but widened after 2019, indicating temporal heterogeneity (P for interaction = 0.026). Black patients underwent surgery less frequently (OR 0.85), experienced more perioperative complications (OR 1.11), and were less often discharged home (OR 0.86). Regionally, mortality was higher among Black patients in the Northeast (OR 1.36) and South (OR 1.14), and among Asian (OR 1.35) and Native American patients (OR 1.47) in the West. Despite improvements in GC admissions and in-hospital mortality, clinically relevant racial and regional disparities in hospital-based outcomes persist, highlighting the need for targeted public health and health system strategies to achieve equitable care.
- 15 May 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (6) , 1129-1131
Gastric indefinite for dysplasia: from diagnostic uncertainty to risk-stratified management
- 15 May 2026
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (6) , 1129-1131
Gastric indefinite for dysplasia: from diagnostic uncertainty to risk-stratified management
- 7 January 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (2) , 347-356
Long-term use of potassium-competitive acid blockers and proton pump inhibitors and the risk of metachronous gastric cancer after H. pylori eradication: a multicenter cohort study
- 7 January 2026
- Published by Springer Nature in Gastric Cancer
- Vol. 29 (2) , 347-356
Long-term use of potassium-competitive acid blockers and proton pump inhibitors and the risk of metachronous gastric cancer after H. pylori eradication: a multicenter cohort study
- 17 December 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (1) , 95-97
Emergent peroral endoscopic myotomy for esophageal motility disorders: defining its evolving clinical role
- 17 December 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (1) , 95-97
Emergent peroral endoscopic myotomy for esophageal motility disorders: defining its evolving clinical role
- 7 October 2025
- Published by Elsevier in Gastroenterology
- Vol. 170 (2) , 425-426
Translating Population-Based Evidence on Helicobacter pylori Eradication Into Precision Surveillance Strategies
- 7 October 2025
- Published by Elsevier in Gastroenterology
- Vol. 170 (2) , 425-426
Translating Population-Based Evidence on Helicobacter pylori Eradication Into Precision Surveillance Strategies
- 18 August 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (3) , 436-437
Colorectal cancer screening from the standpoint of sequential versus simultaneous approaches: insights from the Danish national screening program
- 18 August 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (3) , 436-437
Colorectal cancer screening from the standpoint of sequential versus simultaneous approaches: insights from the Danish national screening program
- 17 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 5714-5721
Impact of hiatal hernia on periprocedural outcomes following peroral endoscopic myotomy: a nationwide retrospective study
The influence of hiatal hernia (HH) presence on peroral endoscopic myotomy (POEM) outcomes remains unclear. This study aimed to compare post-POEM outcomes between patients with and without HH. Using the Nationwide Inpatient Sample from 2016 through 2022, we identified 6572 patients undergoing POEM for achalasia or non-achalasia spastic disorders. One-to-one propensity score matching was performed to compare adverse events, defined as any adverse event associated with an extended length of stay (> 3 days), reintervention, 30-day mortality, and length of stay between the groups. In the propensity score-matched analysis involving 1276 pairs, the HH group had significantly higher rates of adverse events (8.4% vs 6.3%; p = 0.04) and reintervention (7.2% vs 5.3%; p = 0.04) compared to the non-HH group. The most common adverse events were infections, such as peritonitis and mediastinitis (4.9% vs 3.3%; p = 0.04). A longer length of stay (median: 4 vs 3 days; p < 0.01) was observed in the HH group. No significant difference in 30-day mortality was noted between the groups. On logistic regression analysis, HH (OR 1.36; 95% CI 1.06-1.68) and achalasia (vs. non-achalasia spastic disorders; OR 1.54; 95% CI 1.17-2.02) were associated with adverse events. The risk of adverse events and reintervention were higher in the HH group. These findings highlight the need for tailored management in POEM for HH cases. Further prospective studies are required to confirm these results.
- 17 July 2025
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (9) , 5714-5721
Impact of hiatal hernia on periprocedural outcomes following peroral endoscopic myotomy: a nationwide retrospective study
The influence of hiatal hernia (HH) presence on peroral endoscopic myotomy (POEM) outcomes remains unclear. This study aimed to compare post-POEM outcomes between patients with and without HH. Using the Nationwide Inpatient Sample from 2016 through 2022, we identified 6572 patients undergoing POEM for achalasia or non-achalasia spastic disorders. One-to-one propensity score matching was performed to compare adverse events, defined as any adverse event associated with an extended length of stay (> 3 days), reintervention, 30-day mortality, and length of stay between the groups. In the propensity score-matched analysis involving 1276 pairs, the HH group had significantly higher rates of adverse events (8.4% vs 6.3%; p = 0.04) and reintervention (7.2% vs 5.3%; p = 0.04) compared to the non-HH group. The most common adverse events were infections, such as peritonitis and mediastinitis (4.9% vs 3.3%; p = 0.04). A longer length of stay (median: 4 vs 3 days; p < 0.01) was observed in the HH group. No significant difference in 30-day mortality was noted between the groups. On logistic regression analysis, HH (OR 1.36; 95% CI 1.06-1.68) and achalasia (vs. non-achalasia spastic disorders; OR 1.54; 95% CI 1.17-2.02) were associated with adverse events. The risk of adverse events and reintervention were higher in the HH group. These findings highlight the need for tailored management in POEM for HH cases. Further prospective studies are required to confirm these results.
- 15 July 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (8) , 710
Clinical success after peroral endoscopic myotomy in the context of reflux-related symptoms
- 15 July 2025
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 10 (8) , 710
Clinical success after peroral endoscopic myotomy in the context of reflux-related symptoms